Rituximab alone proves effective in the treatment of refractory, severe stage III AIDS-related non-Hodgkin's paediatric lymphoma

This publication has 8 references indexed in Scilit:

• Update on the pathogenesis, diagnosis, and therapy of AIDs-related lymphoma
  Current Infectious Disease Reports, 2003
• Rituximab and chemotherapy is highly effective in patients with CD20-positive non-Hodgkin's lymphoma and HIV infection
  AIDS, 2003
• Acquired immunodeficiency syndrome‐associated lymphomas are efficiently lysed through complement‐dependent cytotoxicity and antibody‐dependent cellular cytotoxicity by rituximab
  British Journal of Haematology, 2002
• Anti-CD20 Monoclonal Antibody (Rituximab) Treatment for Epstein-Barr Virus-associated, B-cell Lymphoproliferative Disease in Pediatric Liver Transplant Recipients
  Journal of Pediatric Gastroenterology and Nutrition, 2002
• Epstein–Barr Virus-Associated Lymphoma in a Child Undergoing an Autologous Stem Cell Rescue
  Journal of Pediatric Hematology/Oncology, 2002
• Infusional CDE with Rituximab for the Treatment of Human Immunodeficiency Virus-Associated Non-Hodgkin’s Lymphoma: Preliminary Results of a Phase I/II Study
  Published by Springer Nature ,2002
• Chimaeric anti‐CD20 monoclonal antibody (rituximab) in post‐transplant B‐lymphoproliferative disorder following stem cell transplantation in children
  British Journal of Haematology, 2001
• Risk of Cancer in Children With AIDS
  Published by American Medical Association (AMA) ,2000